https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-05 / Cancer Gene Ther. 2006 Oct;13(10):905-18
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-05 / Cancer Gene Ther. 2006 Oct;13(10):905-182006-05-05 00:00:002019-02-15 09:19:46Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-04 / Sao Paulo Med J 2006 May;124(3):161-2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-04 / Sao Paulo Med J 2006 May;124(3):161-22006-05-04 00:00:002024-12-03 08:04:16Pure sarcomatous recurrence of clear cell renal carcinoma following radical nephrectomy and dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-01 / Int J Hyperthermia 2006 May;22(3):229-34
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-01 / Int J Hyperthermia 2006 May;22(3):229-342006-05-01 00:00:002019-02-15 08:35:29Cervical cancer: radiotherapy and hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-01 / Rev Recent Clin Trials 2006 May;1(2):87-102
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-01 / Rev Recent Clin Trials 2006 May;1(2):87-1022006-05-01 00:00:002019-02-15 09:19:28Dendritic cell immunotherapy for melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-01 / Ai Zheng 2006 May;25(5):625-30
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-01 / Ai Zheng 2006 May;25(5):625-302006-05-01 00:00:002019-02-15 08:48:11[Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma–a report of ten cases]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-01 / Int J Hyperthermia 2006 May;22(3):235-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-01 / Int J Hyperthermia 2006 May;22(3):235-92006-05-01 00:00:002019-02-15 09:37:53High-risk soft tissue sarcoma: clinical trial and hyperthermia combined chemotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-01 / Clin. Exp. Pharmacol. Physiol. 2006 May-Jun;33(5-6):569-74
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-01 / Clin. Exp. Pharmacol. Physiol. 2006 May-Jun;33(5-6):569-742006-05-01 00:00:002006-05-01 00:00:00Targeting tumours by adoptive transfer of immune cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-01 / Int. J. Cancer 2006 May;118(9):2220-31
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-01 / Int. J. Cancer 2006 May;118(9):2220-312006-05-01 00:00:002006-05-01 00:00:00Short-term dietary administration of celecoxib enhances the efficacy of tumor lysate-pulsed dendritic cell vaccines in treating murine breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-01 / Clin. Cancer Res. 2006 May;12(9):2817-25
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-01 / Clin. Cancer Res. 2006 May;12(9):2817-252006-05-01 00:00:002006-05-01 00:00:00A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-18 / Eur. Urol. 2006 Jul;50(1):34-43
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-18 / Eur. Urol. 2006 Jul;50(1):34-432006-04-18 00:00:002019-02-15 09:17:02Therapeutic dendritic cell vaccination of patients with renal cell carcinoma
